lunes, 2 de mayo de 2016

FDA Approves Parkinson's Psychosis Drug


FDA Approves Drug for Parkinson's Psychosis
Nuplazid is the first medication approved for Parkinson's psychosis (hallucinations and delusions).
Read more about this symptom and new therapy on our blog, then join us Thursday, May 19 for a webinar on Parkinson's psychosis.
Read More >
Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)